[1]杨寿林,宋庆志,吴路发,等.肿瘤标志物和凝血指标在肺癌辅助诊断中的效果分析[J].医学信息,2019,32(07):168-169.[doi:10.3969/j.issn.1006-1959.2019.07.053]
　YANG Shou-lin,SONG Qing-zhi,WU Lu-fa,et al.Efficacy Analysis of Tumor Markers and Coagulation Parameters in the Diagnosis of Lung Cancer[J].Journal of Medical Information,2019,32(07):168-169.[doi:10.3969/j.issn.1006-1959.2019.07.053]
点击复制

肿瘤标志物和凝血指标在肺癌辅助诊断中的效果分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年07期
页码:
168-169
栏目:
诊疗技术
出版日期:
2019-04-01

文章信息/Info

Title:
Efficacy Analysis of Tumor Markers and Coagulation Parameters in the Diagnosis of Lung Cancer
文章编号:
1006-1959（2019）07-0168-02
作者:
杨寿林; 宋庆志; 吴路发; 黎虹妤
（赣州市赣县区人民医院检验科，江西 赣州 341100）
Author(s):
YANG Shou-lin; SONG Qing-zhi; WU Lu-fa; LI Hong-yu
(Department of Laboratory,Ganxian District People's Hospital,Ganzhou 341100,Jiangxi,China)
关键词:
肺癌; 凝血指标; 肿瘤标志物
Keywords:
Lung cancer; Coagulation index; Tumor markers
分类号:
R734.2；R730.43
DOI:
10.3969/j.issn.1006-1959.2019.07.053
文献标志码:
A
摘要:
目的 探析肺癌辅助诊断中肿瘤标志物与凝血指标的诊断价值。方法 将2016年2月~2018年11月我院收治的48例肺癌患者纳入研究组，将同期48例健康体检人员纳入对照组，通过电化学发光仪和全自动血凝分析仪检测患者肿瘤标志物和凝血指标，肿瘤标志物包括鳞状细胞癌相关抗原（SCC）、癌胚抗原（CEA）、细胞角蛋白19（CYFRA21-1）和神经元特异性烯醇化酶（NSE）；凝血指标包括D-二聚体（D-dimer）、纤维蛋白原（FIB）、活血部分凝血活酶时间（APTT）、凝血酶时间（TT）及血浆凝血酶原时间（PT）。结果 在SCC、CYFRA21-1、CEA及NSE方面，研究组均高于对照组，差异存在统计学意义（P＜0.05）；研究组TT低于对照组，而D-dimer、FIB高于对照组，差异均有统计学意义（P＜0.05）；两组APTT及PT分别比较，差异均无统计学意义（P＞0.05）。结论 根据CEA、CYFRA21-1、NSE及FIB指标水平，有助于肺癌疾病诊断准确率的提高，根据肿瘤标志物及凝血指标数值，有助于判断肺癌发展状况。
Abstract:
Objective To investigate the diagnostic value of tumor markers and coagulation parameters in the diagnosis of lung cancer. Methods 48 patients with lung cancer admitted to our hospital from February 2016 to November 2018 were enrolled in the study group. 48 healthysubjects were included in the control group, and the tumor markers were detected by electrochemiluminescence and automatic hemagglutination analyzer. And coagulation indicators, tumor markers including squamous cell carcinoma associated antigen (SCC), carcinoembryonic antigen (CEA), cytokeratin 19 (CYFRA21-1) and neuron specific enolase (NSE); coagulation indicators include D-dimer, fibrinogen (FIB), viable partial thromboplastin time (APTT), thrombin time (TT), and plasma prothrombin time (PT). Results In the SCC, CYFRA21-1, CEA and NSE, the study group was higher than the control group, the difference was statistically significant (P<0.05); the study group TT was higher than the control group, and the D-dimer was lower than the control group, the difference All of them were statistically significant (P<0.05). There were no significant differences in APTT and PT between the two groups (P>0.05). Conclusion According to CEA, CYFRA21-1, NSE and FIB levels, it can help to improve the accuracy of lung cancer diagnosis. According to the tumor markers and coagulation index values, it can help to judge the development of lung cancer.

参考文献/References:


[1]吴园园,管世鹤,杨凯,等.血清肿瘤标志物在肺癌辅助诊断中的应用[J].中国微生态学杂志,2017,29(5):547-549.
[2]单新洁,祁晓婷,俞荣.4项血清肿瘤标志物联合检测在肺癌中的应用价值分析[J].河北医科大学学报,2018,39(7):833-837.
[3]张海晨,王浩,宋云霄,等.多项肿瘤标志物联合检测模型在肺癌诊断中的应用价值[J].检验医学,2018,33(7):590-596.
[4]范润萍,徐笑红.NLR、LDH结合几种常见肿瘤标志物在肺癌诊断中的价值[J].中国医师杂志,2017,19(6):895-898.
[5]舒媚,吴振兴,朱振亮,等.血清肿瘤标志物联合检测在肺癌诊断中的价值[J].中华全科医学,2016,14(6):1019-1021.
[6]余洲海,孟伟.联合检测血清中四种肿瘤标志物对肺癌的诊断价值评估[J].标记免疫分析与临床,2016,23(6):655-658.
[7]刘俊,孙璀.血清肿瘤标志物单独或联合检测在原发性肺癌中的诊断价值[J].检验医学与临床,2017,14(19):2887-2889.
[8]徐一凯,陈素珍,胡丹丹,等.肿瘤标志物神经特异性烯醇化酶与糖链抗原125及血清细胞角蛋白19片段和癌胚抗原在肺癌诊断与分期中的价值[J].中国临床保健杂志,2017,20(5):498-501.
[9]杨含,罗素霞.六种肿瘤标志物在肺癌诊断中的价值及其临床应用[J].现代肿瘤医学,2016,24(4):577-581.
[10]戎荣,程义壮,沈佐君.四种血清肿瘤标志物联合检测在肺癌诊断中的价值[J].山东医药,2018,58(1):78-80.

相似文献/References:

[1]尤 静.肺癌患者外周血CEA、NSE、CYFRA21-1联合检测的意义[J].医学信息,2018,31(06):149.[doi:10.3969/j.issn.1006-1959.2018.06.052]
　YOU Jing.Clinical Significance of Combined Detection of CEA,NSE,CYFRA21-1 in Peripheral Blood of Patients with Lung Cancer[J].Journal of Medical Information,2018,31(07):149.[doi:10.3969/j.issn.1006-1959.2018.06.052]
[2]戴 芳,曹晓美,王莉娜.肺癌患者疾病不确定感的影响因素与干预措施研究现状[J].医学信息,2018,31(08):35.[doi:10.3969/j.issn.1006-1959.2018.08.012]
　DAI Fang,CAO Xiao-mei,WANG Li-na.Research Status on Influencing Factors and Intervention Measures of Disease Uncertainty in Patients with Lung Cancer[J].Journal of Medical Information,2018,31(07):35.[doi:10.3969/j.issn.1006-1959.2018.08.012]
[3]吴 倩,王一非.中西医结合治疗肺癌脑转移疗效与安全性的Meta分析[J].医学信息,2022,35(10):120.[doi:10.3969/j.issn.1006-1959.2022.10.029]
　WU Qian,WANG Yi-fei.Meta-analysis of Efficacy and Safety of Integrated Traditional Chinese and Western Medicine in the Treatment of Brain Metastasis of Lung Cancer[J].Journal of Medical Information,2022,35(07):120.[doi:10.3969/j.issn.1006-1959.2022.10.029]
[4]王晓军.以时间护理为基础的呼吸训练与排痰管理对肺癌手术患者康复的影响研究[J].医学信息,2022,35(11):180.[doi:10.3969/j.issn.1006-1959.2022.11.048]
　WANG Xiao-jun.Effect of Respiratory Training and Expectoration Management Based on Time Nursing on Rehabilitation of Patients with Lung Cancer Surgery[J].Journal of Medical Information,2022,35(07):180.[doi:10.3969/j.issn.1006-1959.2022.11.048]
[5]邢益辉,刘 曼,厉玛倩倩,等.快速康复对肺癌手术患者并发症发生及生活质量的影响研究[J].医学信息,2018,31(16):168.[doi:10.3969/j.issn.1006-1959.2018.16.054]
　XING Yi-hui,LIU Man,LIMA Qian-qian,et al.Effect of Rapid Rehabilitation on Complications and Quality of Life in Patients with Lung Cancer Surgery[J].Journal of Medical Information,2018,31(07):168.[doi:10.3969/j.issn.1006-1959.2018.16.054]
[6]朱晓晓,张 顺,蔡 挺.镍暴露相关的肺癌发生分子机制研究[J].医学信息,2018,31(17):4.[doi:10.3969/j.issn.1006-1959.2018.17.002]
　ZHU Xiao-xiao,ZHANG Shun,CAI Ting.Molecular Mechanism of Lung Cancer Related to Nickel Exposure[J].Journal of Medical Information,2018,31(07):4.[doi:10.3969/j.issn.1006-1959.2018.17.002]
[7]付云杰.肺癌患者血浆D-二聚体、NSE及CYFRA21-1联合检测的临床价值[J].医学信息,2018,31(23):161.[doi:10.3969/j.issn.1006-1959.2018.23.047]
　FU Yun-jie.Clinical Value of the Plasma D-dimer and Serum NSE,CYFRA21-1 Combined Detection in the Diagnosis of Lung Cancer[J].Journal of Medical Information,2018,31(07):161.[doi:10.3969/j.issn.1006-1959.2018.23.047]
[8]覃柳麻,何慧敏.2014~2016年广西肿瘤医院肺癌患者流行病学及病理分布特征分析[J].医学信息,2019,32(05):67.[doi:10.3969/j.issn.1006-1959.2019.05.021]
　QIN Liu-ma,HE Hui-min.Epidemiological and Pathological Distribution Characteristics of Lung Cancer Patients in Guangxi Cancer Hospital from 2014 to 2016[J].Journal of Medical Information,2019,32(07):67.[doi:10.3969/j.issn.1006-1959.2019.05.021]
[9]魏优蕾,郭晓彤.肺癌患者血浆检测肿瘤标志物的分析方法及展望[J].医学信息,2019,32(07):39.[doi:10.3969/j.issn.1006-1959.2019.07.014]
　WEI You-lei,GUO Xiao-Tong.Analytical Methods and Prospects of Plasma Detection of Tumor Markers in Patients with Lung Cancer[J].Journal of Medical Information,2019,32(07):39.[doi:10.3969/j.issn.1006-1959.2019.07.014]
[10]王 猛.循环肿瘤细胞在肺癌诊疗中的临床研究进展[J].医学信息,2019,32(15):58.[doi:10.3969/j.issn.1006-1959.2019.15.019]
　WANG Meng.Progress in Clinical Research of Circulating Tumor Cells in the Diagnosis and Treatment of Lung Cancer[J].Journal of Medical Information,2019,32(07):58.[doi:10.3969/j.issn.1006-1959.2019.15.019]

更新日期/Last Update: 2019-04-01